FILTER
FILTERED INTERVIEW RESULTS
Krishna Kanumuri
CEO & MANAGING DIRECTOR, SAI LIFE SCIENCES
"The biotech industry in India is currently extremely nascent, but it is evolving fast as generic margins drop, and many companies are starting to explore more innovative approaches to doing business. I anticipate Sai will take on more companies in the biotech sector in the future."
Bindi Chudgar
MANAGING DIRECTOR, LAMBDA THERAPEUTIC RESEARCH
"With our expanding global footprint, we firmly believe that we are well positioned to achieve the vision of creating benchmarks and shaping the future of the clinical research industry by ensuring quality, reliability, and value-added services.”
Karan Singh
MANAGING DIRECTOR, ACG
"Personalized medicine will disrupt the pharma industry. I also see more people looking to leverage the digitization of patient care, such as through telemedicine or the creation of wearable technologies."
Dr. Hemant Koshia
COMMISSIONER, FDCA (FOOD AND DRUG CONTROL ADMINISTRATION) GUJARAT
"In addition to pharmacy graduates, the pharmaceutical industry requires support from other industries like chemicals and petrochemicals, as well as top quality pharmacy machinery manufacturers. In Gujarat, we have all of this."
Mohal Sarabhai
CEO, ASENCE PHARMA PRIVATE LIMITED
"We are working closely with our US partners to bring one of the most affordable point of care testing (POCT) devices to the market that will be saliva-based to provide the accuracy of a PCR machine on a POC device."
Sudheendra Kulkarni
CEO, SOUTH ASIA & ASEAN FERRING PHARMACEUTICALS
Ferring is a global biopharmaceutical company based in Switzerland that has one of the most comprehensive footprints in India.
Milind Antani and Darren Punnen
LEAD - PHARMA, HEALTHCARE, MEDICAL SERVICE AND DIGITAL HEALTH PRACTICE & LEADER - PHARMA AND LIFE SCIENCES PRACTICE, NISHITH DESAI ASSOCIATES (NDA)
Practice, Nishith Desai Associates (NDA) speak about legal developments relating to India’s life sciences industry
Lakshmi Prasanna Chundu
DIRECTOR - REGULATORY AFFAIRS, THE PHARMACEUTICAL EXPORT PROMOTION COUNCIL OF INDIA (PHARMEXCIL)
Pharmexcil explains how the agency is promoting India’s life sciences exports, which aim to reach US$40 billion in five years.
Daara Patel
SECRETARY GENERAL, INDIAN DRUG MANUFACTURERS’ ASSOCIATION (IDMA)
"Today, India's pharmaceutical sector is a US$50 billion industry and we anticipate it growing to at least US$150 billion in less than a decade."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
Peru Mining 2025 Pre-Release II
Featuring insights from nearly 50 mining executives, the second pre-release edition of GBR's Peru Mining 2025 sheds light on the industry's current state while highlighting the country's window of opportunity with the energy transition and copper's critical role.
Featuring insights from nearly 50 mining executives, the second pre-release edition of GBR's Peru Mining 2025 sheds light on the industry's current state while highlighting the country's window of opportunity with the energy transition and copper's critical role.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
